Trials / Completed
CompletedNCT03396900
Periodontally Accelerated Osteogenic Orthodontics With BMP2
Periodontally Accelerated Osteogenic Orthodontics Combined With Recombinant Human Bone Morphogenetic Protein-2: An Outcome Assessment
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- SVS Institute of Dental Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
rhBMP-2 has the potential to function as a regenerative material in periodontally accelerated osteogenic orthodontics (PAOO). This study aimed to assess the effects of PAOO with BMP-2 on outcomes such as treatment period, bone density, healing and pain.
Detailed description
Subjects were randomly assigned into each of the following experimental groups; C+BMP: corticotomy with 0.5 μg/mL rhBMP-2 and C: corticotomy only. Clinical parameters included recording the duration of treatment period, visual analogue scale (VAS) scores and early healing index (EHI) scores. The evaluation of bone density was performed at baseline, 3 months and 6 months by using RVG.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | RhBMP-2 Protein, Recombinant | Bone morphogenetic proteins (BMPs) are a category of proteins that are involved in bone formation and repair. Among these, BMP-2 is one of the most potent members of the BMP family and has been used for correcting intrabony, supraalveolar, furcation, and fenestration defects due to its osteoinductive property. BMP's are also essential for differentiation of osteoclasts, but their role in this process remains unclear. Treatment of osteoclasts with exogenous BMP-2 directly enhances RANKL-stimulated differentiation of osteoclast precursors in vitro and stimulates survival and resorptive activity of mature osteoclasts that accelerates the tooth movement. |
| OTHER | Conventional Corticotomy | A conventional PAOO Surgical procedure will be performed for individuals in this arm |
Timeline
- Start date
- 2016-07-01
- Primary completion
- 2017-08-01
- Completion
- 2017-11-01
- First posted
- 2018-01-11
- Last updated
- 2018-01-11
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT03396900. Inclusion in this directory is not an endorsement.